ExcitePCR has two products in development: the FireflyDX-Portable™ and the FireflyDX-Handheld™ … lightweight & portable realtime pathogen detection systems slated for availability in 2018 & 2019, respectively.
Pleasanton, Calif. (PRWEB)
August 30, 2017
ExcitePCR Corporation is developing portable realtime pathogen detection systems based upon superior PCR (Polymerase Chain Reaction) methodologies. Its FireflyDX™ technologies will deliver automated Point-of-Need / Point-of-Care (PON / POC) sample preparation and highly accurate biohazard identification significantly faster than using existing PCR-based solutions.
ExcitePCR™ traces its roots back to 2004 when Microfluidic Systems was one of seven companies awarded contracts by the U.S. Department of Homeland Security to develop a solution to automatically detect airborne pathogens. Over the next seven years, Microfluidic was the only company to meet the DHS requirements as the firm developed what it named the M-BAND™ system, a refrigerator-sized pathogen detection solution. From 2004 — 2011, Microfluidic received over $35 million in DHS funding before being acquired in 2011 by PositiveID with the express intent of developing portable realtime biohazard detection systems. Concurrently, the company proved it could miniaturize the critical components of the M-BAND to a fraction of the size into a non-commercialized system called the Dragonfly™. Then in 2017, ExcitePCR was formed as a standalone corporation designed to commercialize the company’s FireflyDX technologies.
Simplified Technical Background: